IOVA
IOVANCE BIOTHERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$8.70
−1.47%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 35.59x
- P/S forward
- 7.01x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.35x
- Price / sales
- 12.13x
- Price / cash flow
- -14.92x
Enterprise value
- Enterprise value
- $3.7B
- EV / sales
- 11.35x
- EV / EBITDA
- -14.69x
- EV / EBIT
- -12.46x
- Market cap
- $3.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026